CAR-T and CAR-NK cell therapies

In this episode of Talking Techniques, Ritwika Biswas, Field Scientist at Sino Biological US Inc. (PA, USA), walks us through the chimeric antigen receptor (CAR) development process and how T and natural killer (NK) cells can be utilized to carry these modular synthetic molecules. Ritwika also addresses the safety and efficacy of these cell therapies as well as the ethical considerations around them.

Hosted on Acast. See acast.com/privacy for more information.

More from Talking Techniques

  1. 23:58Spatial analysis of the immune-cell-surface proteome at a single-cell resolutionMar 22, 2024
  2. 34:27Investigating the neurological pathways underlying vocal communicationFeb 20, 2024
  3. 20:18Rare disease and pharmacogenomicsJan 23, 2024
  4. 20:47One man’s waste in another man’s treasure: using wastewater to monitor infectious diseasesDec 18, 2023
  5. 24:52Next-generation antibody therapeuticsNov 22, 2023
  6. 09:50Investigating resistant leukemia with single-cell technologiesNov 03, 2023
  7. 27:35CAR-T and CAR-NK cell therapiesJul 27, 2023
  8. 24:28Mitochondria, the immune system and cancer: discovering new insights with spatial technologiesJun 16, 2023
  9. 22:18Long-read sequencing, metagenomics and the microbiomeMay 10, 2023
  10. 37:53Open neuroscience and the meaning of FAIRFeb 03, 2023